A total of eight studies[13–14,16–20,22] reported EpCAM overexpression in positive and negative lymph node metastases groups of gastric cancer tissues.The I2 estimate indicated significant heterogeneity (I2 = 84%) amongthe studies, and the random effects model used in thismeta-analysisindicated that the expression of EpCAM in the positive group (LN+) was greater than that in the negative group (LN−). Here, EPCAM is linked to gastric cancer.